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S1-General chemistry experimental details
All reactions were carried out under an argon atmosphere unless otherwise stated. Starting materials were purchased commercially and were used as received. Solvents were dried using an Innovative Technology solvent purification system and were stored in ampoules under argon.
TLC analysis was carried out using Merck Silica gel 60 F254 TLC plates and spots were visualised using a TLC lamp emitting at 365, 312 or 254 nm. Silica gel column chromatography was performed using silica gel 60 purchased from Sigma Aldrich. 1 H and 13 C NMR spectroscopy was carried out on Bruker AV400, Varian VNMRS 500 and 700, and Varian Inova 500 NMR spectrometers. Residual solvent peaks were referenced as described in the literature 1 , and all NMR data was processed in MestReNova V11.
Melting points were carried out on a Stuart SMP40 machine with a ramping rate of 4 °C min −1 .
Videos were replayed manually to determine the melting point.
High resolution mass spectrometry was carried out on a Waters LCT Premier XE using ASAP ionisation. Samples were analysed directly as solids.
Elemental analysis was performed on an Exeter Analytical E-440 machine 1-Methylphenothiazine, 1-iso-propylphenothiazine and 1-tert-butylphenothiazine were prepared according to literature procedures. 
S2 -Synthetic procedures and characterisation data
Synthesis of 2,8-Bis(10H-phenothiazin-10-yl)dibenzo[b,d]thiophene (DPTZ-DBT)
2,8-Dibromodibenzothiophene (268 mg, 0.783 mmol, 1 eq.) and phenothiazine (312 mg, 1.566 mmol, 2 eq.) were dried under vacuum for 30 min in a two-neck 100 mL round-bottomed flask fitted with a reflux condenser. The flask was back-filled with argon and dry toluene (20 mL) was added. The reaction mixture was bubbled with argon for 30 min, then Pd2(dba)3·CHCl3 (41 mg, 39 μmol, 0.05 eq.) and HP t Bu3BF4 (23 mg, 79 μmol, 0.10 eq.) were added and the reaction mixture was bubbled with argon for a further 30 min. NaO t Bu (225 mg, 2.34 mmol, 3 eq.) was added under a high flow of argon and the reaction was then heated to 115 C (DrySyn kit temperature) with stirring for 17 h. At the end of the reaction CHCl3 (70 mL) was added followed by water (70 mL). The organic layer was separated and the aqueous layer was extracted further with CHCl3 (2 × 70 mL). The organic extracts were combined and were dried with MgSO4 and filtered. The solvent was removed under reduced pressure and the crude mixture was purified by silica gel column chromatography with gradient elution from 20% v/v CHCl3/hexane switching to 100% CHCl3 in 20% increasing increments. Removal of solvent under reduced pressure gave a yellow solid. Recrystallization of the residue from boiling hexane with slow addition of chloroform followed by hot filtration and cooling to −18 °C gave S3 DPTZ-DBT as a cream-yellow crystalline solid (205 mg, 45% yield). The molecule was sublimed by heating at > 300 C under vacuum (9 × 10 −2 mbar). Crystals suitable for X-ray diffraction were obtained by slow evaporation from CDCl3 and allowing for complete solvent evaporation. 1 Bu3BF4 (93 mg, 320 μmol, 0.1 eq.) were added and the reaction mixture was bubbled with argon for an additional 30 min. NaO t Bu (0.92 g, 9.57 mmol, 3 eq.) was added under a high flow of argon and the reaction was heated to 115 °C (DrySyn kit temperature) with stirring for 20 h. After being cooled down to room temperature, the reaction mixture was quenched with water (50 mL) and extracted with CHCl3 (2 × 70 mL). The combined organic layers were dried with MgSO4 and filtered. The solvent was removed under reduced pressure and the crude mixture was purified by silica gel chromatography with gradient elution from 25% v/v CHCl3/hexane switching to 100% CHCl3 in 25% increasing increments. Removal of solvent under reduced pressure resulted in product as a yellow solid. Recrystallization from 20% v/v CHCl3/hexane mixture gave DPTZ-Me-DBT as a greenish solid (1.34 g, 69% yield). Crystals suitable for X-ray diffraction were obtained by slow evaporation from CHCl3/hexane (30/70 v/v). 1 Optical spectroscopy. Absorption and emission spectra were collected using a Shimadzu UV-3600 double beam spectrophotometer, and a Jobin Yvon Fluorolog fluorescence spectrometer, respectively. Emission is independent of excitation wavelength. Steady-state fluorescence was collected with excitation at 355 nm. The luminescence temperaturedependence measurements were acquired using a model liquid nitrogen cryostat (Janis Research). Fluorescence decays under 10 ns were measured in a TCSPC system equipped with a Becker&Hickl card. The excitation source was the third harmonic (290 nm) of a ps pulsed Ti:Sa laser, Coherent, with 2 ps pulse width, and detection made using a Hamamatsu MCPT detector. The IRF of the system is under 23 ps. For longer lifetimes, a DeltaFlex TCSPC system from Horiba was used with LED excitation at 357 nm, and 1.5 ns IRF. Phosphorescence time-resolved spectra and decays were recorded using nanosecond gated luminescence, and lifetime measurements (from 1 ns to 1 s) using a pulsed Nd:YAG laser, with second harmonic emission at 355 nm (EKSPLA). Emission was focused onto a spectrograph and detected on a sensitive gated iCCD camera (Stanford Computer Optics) with sub-nanosecond resolution. Solutions were prepared with concentrations in the 10 -5 -10
M range in different solvents, and samples were degassed using 5 freeze/thaw cycles. Films for optical characterization were prepared in zeonex matrix by drop-casting or spin-coating onto a quartz substrate with an emitter/zeonex ratio of 1: 20 (w/w).
For PLQY determination, films were prepared by drop-casting onto a quartz substrate with a lower emitter/zeonex ratio of 0.1: 99.9 (w/w) to prevent aggregation and reabsorption phenomena. Phosphorescence quantum yields were calculated using each compound ϕF as internal reference and the ratio of integrated areas of luminescence spectra acquired with and without oxygen, as given by equation S1,
where Ivac and Iair are the integrals calculated for spectra in wavelength form.
Flash Photolysis Studies. Triplet lifetimes were determined in degassed benzene using a flash photolysis setup composed of a LKS. 60 ns laser photolysis spectrometer from Applied Photophysics, with a Brilliant Q-Switch Nd:YAG laser from Quantel, using the third harmonics (ex = 355 nm, laser pulse half-width equal to 6 ns). First-order kinetics were observed for the decay of the lowest triplet state (T-T annihilation was prevented by the low excitation energy and/or low optical density at excitation wavelength, A355nm ≤0.1).
The transient spectra were obtained with the same apparatus by monitoring the optical density change at intervals of 10 nm over the 300-600 nm range and averaging at least 32 decays at each wavelength.
S12
The T values for compounds DPTZ-DBT, DPTZ-Me-DBT, DPTZ-i Pr-DBT were determined with the flash photolysis setup using the energy transfer method previously described, where 2-acetylnaphthalene and -carotene where used as triplet standard and quencher, respectively.
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Compound DPTZ-t Bu-DBT exhibited significant degradation under laser excitation and triplet transient absorption decays could not be separated from the photoproduct formation. Thus, a different method using a lower intensity excitation source was required. We employed a modified olefin isomerization method developed by Lamola and Hammond. 
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S5 -Computational data
Computational Details. The ground and excited state geometries of all structures were optimized using (time-dependent) density functional theory within the approximation of the M062X exchange and correlation functional 4 as implemented within the Gaussian Quantum Chemistry package. 5 A Def2-SVP basis set was used throughout. To aid convergence, the effect of the solvent was not included during the geometry optimizations. However, all excited state energies included the solvent effect using a polarizable continuum model and the dielectric constant of toluene, anisole or ethanol. Fluorescence and phosphorescence energies were calculated using the S1 and T1 optimized geometries and a state-specific polarizable continuum model (SS-PCM). 6 Following recent work, 7 both the H-intra and Hextra folded conformers of the phenothiazine that allow formation of parallel quasi-axial (ax) and perpendicular quasi-equatorial (eq) conformers were investigated. However, in both cases one dominant conformer was found for both DPTZ-DBT and DPTZ-t Bu-DBT. For the former, both donor groups are equatorial to the acceptor, while in DPTZ-t Bu-DBT both donor groups are axial to the acceptor. The spin-orbit coupling calculations were performed using the Q-chem quantum chemistry software. 14 Crystal data and experimental details are listed in Table S1 . (Table S3) .
Slow evaporation of a DPTZ-DBT solution in CDCl3, yielded concomitantly two crystalline phases, DPTZ-DBT·CDCl3 and DPTZ-DBT·½CDCl3. In both structures, the asymmetric unit contains one host molecule with both PTZ groups adopting equatorial orientations, the cavity between these groups filled by a disordered CDCl3 molecule of crystallisation (Fig. S16 ). In the monosolvate, both PTZ moieties are folded outwards, while in the hemisolvate, one is folded outward and the other inward; the latter has a narrower θ angle (145°) that the rest (155-157°).
Crystallisation of DPTZ-Me-DBT from chloroform/hexane solution yielded in succession three crystalline phases, viz. chloroform monosolvate, solvent-free monoclinic and solvent-free triclinic. The asymmetric unit of DPTZ-Me-DBT·CDCl3 comprises two host molecules (and two chloroform molecules), both adopting a trans-axial-conformation (Fig. S17a) . In one molecule, the methyl substituents at both PTZ moieties are disordered, i.e. different conformers share the site, while the other molecule shows no disorder. The monoclinic unsolvated phase (Fig. S17b) has one independent molecule, which adopts a cis-axial-conformation. One whole PTZ-Me moiety is disordered between two orientations with methyl substituent on opposite sides, with occupancies refined to 0.769(3) and 0.231(3). The moiety is pivoted around N(1) so as to maximise the steric overlap between two conformers. The other PTZ moiety is ordered but its methyl substituent is distributed between two positions in a 0.7:0.3 ratio. The triclinic phase also has one independent molecule with one PTZ moiety ordered and the other disordered in a 2:1 ratio, but in contrast to the monoclinic polymorph, the overall conformation is trans-axial (Fig. S17c) . Curiously, the minor PTZ conformation has the methyl substituent further disordered (occupancies 0.25 and 0.08). The molecule of DPTZi Pr-DBT has crystallographic C2 symmetry and thus a trans-axial-conformation (Fig. S18), showing no disorder. 
